Description
Approved uses for Crikzo include:
- Non-small cell lung cancer (NSCLC): Used for NSCLC that has spread (metastatic) and is caused by a defect in the ALK or ROS1 gene. A doctor will perform a genetic test to determine if the medication is appropriate.
- Other cancers: It may also be prescribed for certain anaplastic large cell lymphoma (ALCL) and inflammatory myofibroblastic tumors (IMT) in adults and children.
Who is the CFA, distributor, and retailer for Crikzo (Crizotinib) Capsules in India?
Crikzo (Crizotinib) Capsules are managed and supplied in India through Aark Pharmaceuticals, the authorised and government-approved CFA, distributor, and retailer. Crikzo (Crizotinib) Capsules are available across India on request, with access in major cities including Delhi, Gurgaon, Noida, Kanpur, Mumbai, Indore, Kolkata, Ludhiana, Hyderabad, Kochi, Bengaluru, Vijayawada, Chennai, Bhopal, Pune, Nashik, Lucknow, Madurai, Ahmedabad, Vadodara, Patna, Prayagraj (Allahabad), Jaipur, Meerut, Agra, Jabalpur, Varanasi, Visakhapatnam, Coimbatore, Asansol, Nagpur, and Surat.
How much do Crikzo Capsules cost in Delhi, India?
Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
Do you offer any discounts?
Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price.
Prior to consuming any medications, including Crizotinib Capsules, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
NEWS/UPDATES
- Brukinsa (zanubrutinib).
- BRUKINSA: explore the possibilities in CLL.
- Rare blood cancer gets drug approved for use on NHS.
- FDA Approves Zanubrutinib Tablet for All IndicationsFDA Approves Taletrectinib in ROS1+ NSCLC.
